No Data
No Data
Masimo Announces Leadership Transition
Stryker Shares Are Trading Higher After the Company Announced It's Commencing a Tender Offer to Acquire the Outstanding Stock of Inari Medical for $80 per Share in Cash.
Stryker Commences Tender Offer for All Outstanding Shrs of Common Stock of Inari Medical
Are You Looking for a Top Momentum Pick? Why Inari Medical, Inc. (NARI) Is a Great Choice
Biopharmaceutical newcomer Intra-Cellular surged over 25% before the market opened! It is reported that Johnson & Johnson is in talks to acquire the company, reigniting a wave of Medical mergers and acquisitions.
Johnson & Johnson is in talks to acquire the biopharmaceutical company Intra-Cellular Therapies Inc., which focuses on treating central nervous system diseases, and both parties may reach an agreement as early as this week.
Plug Power, Capri And Frontline Are Among Top Mid Cap Gainers Last Week (Jan 6-10): Are The Others In Your Portfolio?